Healthcare - Biotechnology - NASDAQ - US
$ 2.15
-7.73 %
$ 9.84 M
Market Cap
-0.12
P/E
BALANCE SHEET
119 M
ASSETS
52.6 M
LIABILITIES
66.9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Senti Biosciences, Inc.
| Current Assets | 71.2 M |
| Cash & Short-Term Investments | 35.9 M |
| Receivables | 17.7 M |
| Other Current Assets | 17.6 M |
| Non-Current Assets | 48.3 M |
| Long-Term Investments | 4.64 M |
| PP&E | 41.6 M |
| Other Non-Current Assets | 2.03 M |
| Current Liabilities | 12.7 M |
| Accounts Payable | 1.25 M |
| Short-Term Debt | 4.13 M |
| Other Current Liabilities | 7.29 M |
| Non-Current Liabilities | 39.9 M |
| Long-Term Debt | 33.5 M |
| Other Non-Current Liabilities | 6.36 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 35.9 | 57.6 | 56.0 | 30.5 | 5.3 |
| Short Term Investments | 0 | 40.9 | 1.2 | 25 K | 12.5 |
| Receivables | 17.7 | 0.6 | 0.5 | 0.3 | 78 K |
| Inventory | 0 | 3.3 | 2.6 | 25 K | 0 |
| Other Current Assets | 17.6 | 3.4 | 3.7 | 0.9 | 0.9 |
| Total Current Assets | 71.2 | 102.6 | 60.2 | 31.7 | 18.8 |
| PP&E | 41.6 | 74.6 | 33.1 | 16.1 | 16.6 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 4.6 | 3.4 | 3.3 | 0 | 0 |
| Other Long Term Assets | 2.0 | 0.3 | 0.2 | 0.5 | (16.6) |
| Other Assets | 1 | 0 | 0 | 0 | 0.5 |
| Total Assets | 119.5 | 180.8 | 96.7 | 48.3 | 35.8 |
| LIABILITIES | |||||
| Accounts Payable | 1.2 | 1.4 | 5.2 | 0.9 | 1.2 |
| Short Term Debt | 4.1 | 4.0 | 1.7 | 1.5 | 0 |
| Other Current Liabilities | 6.3 | 11.9 | 6.0 | 2.4 | 3.1 |
| Total Current Liabilities | 12.7 | 18.1 | 14.5 | 4.9 | 4.3 |
| Long Term Debt | 33.5 | 35.1 | 21.0 | 12.5 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 6.4 | 0.4 | 172.5 | 89.7 | 0 |
| Total Liabilities | 52.6 | 53.5 | 208.2 | 107.1 | 17.9 |
| EQUITY | |||||
| Common Stock | 5 K | 4 K | 1 K | 1 K | 1 K |
| Retained Earnings | (244.3) | (173.3) | (115.1) | (59.8) | (39.9) |
| Other Accumulative Comprehensive Income/Loss | 0 | 1 K | (171.8) | (89.7) | 0 |
| Total Equity | 66.9 | 127.3 | (111.5) | (58.7) | 18.0 |
| Total Liabilities and Equity | 119.5 | 180.8 | 96.7 | 48.3 | 0 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 4.4 | 2.6 | 4.4 | 4.4 | 13.6 |